Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|---|---|---|
| Total revenue | revenue | 2.77B | 22.96% |
| Gross profit | profit | 1.83B | 25.57% |
| Total cost of revenue | cost | 940.30M | 18.17% |
| Interest and other income, net | revenue | 85.10M | -5.86% |
| Income from operations | profit | 855.30M | 47.95% |
| Total operating expenses | cost | 975.20M | 10.87% |
| Income before taxes | profit | 940.40M | 40.67% |
| Selling, general, and administrative | cost | 613.30M | 8.86% |
| Research and development | cost | 361.90M | 14.45% |
| Net income | profit | 826.00M | 17.38% |
| Income tax expense (benefit) | cost | 114.40M | 225.00% |
| Total comprehensive income | profit | 799.70M | 9.85% |
| Unrealized gains (losses) on hedge instruments | revenue | 9.90M | 1.95% |
| Other comprehensive income (loss) | revenue | 26.30M | 8.23% |
| Total comprehensive income attributable to intuitive surgical, inc. | profit | 794.70M | 9.98% |
| Less: comprehensive income attributable to noncontrolling interest | cost | 5.00M | -7.41% |
| Aggregate | profit | 36.20M | |
| Unrealized gains (losses) on available-for-sale securities | revenue | 23.60M | -1.81% |
| Foreign currency translation gains (losses) | revenue | 11.50M | -3.09% |
| Other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, after tax | cost | 1.10M | 12.00% |
| Segment | Value | YoY |
|---|---|---|
| Instruments and Accessories | 1.69B | 23.30% |
| Systems | 650.70M | 24.49% |
| Services | 433.70M | 19.48% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Short- term investments | assets | 2.51B | |
| Cash and cash equivalents | assets | 2.01B | |
| Inventory | assets | 1.95B | |
| Accounts receivable, net | assets | 1.60B | |
| Prepaids and other current assets | assets | 751.50M | |
| Total current assets | assets | 8.81B | |
| Property, plant, and equipment, net | assets | 5.45B | |
| Long- term investments | assets | 3.46B | |
| Intangible and other assets, net | assets | 1.09B | |
| Deferred tax assets | assets | 683.80M | |
| Goodwill | assets | 613.20M | |
| Total assets | assets | 20.11B | |
| Total stockholders’ equity | liabilities | 17.60B | |
| Total liabilities | liabilities | 2.51B | |
| Noncontrolling interest in joint venture | liabilities | 122.70M | |
| Total intuitive surgical, inc. stockholders’ equity | equity | 17.47B | |
| Total current liabilities | liabilities | 1.91B | |
| Other long-term liabilities | liabilities | 602.80M | |
| Additional paid-in capital | equity | 11.06B | |
| Retained earnings | equity | 6.40B | |
| Accumulated other comprehensive income | equity | 16.50M | |
| Common stock, 600.0 shares authorized, $0.001 par value, 354.4 shares and 355.1 shares issued and outstanding as of march 31, 2026, and december 31, 2025, respectively | equity | 400000 | |
| Other accrued liabilities | liabilities | 647.90M | |
| Deferred revenue | liabilities | 559.50M | |
| Accrued compensation and employee benefits | liabilities | 370.70M | |
| Accounts payable | liabilities | 332.90M |
| Item | Value |
|---|---|
| Net income | 826.00M |
| Increase (decrease) in deferred income taxes | 339.30M |
| Share-based compensation expense | 209.50M |
| Depreciation and loss on disposal of property, plant, and equipment | 178.90M |
| Accounts payable | 73.90M |
| Deferred revenue | 46.10M |
| Other liabilities | 30.70M |
| Increase (decrease) in accounts receivable | 25.10M |
| Amortization of intangible and other assets | 21.10M |
| Gain on sale of business and assets | -7.90M |
| Accretion (amortization) of discounts and premiums, investments | -10.20M |
| Increase (decrease) in inventories | -266.60M |
| Increase (decrease) in prepaid expense and other assets | -269.30M |
| Accrued compensation and employee benefits | -284.70M |
| Item | Value |
|---|---|
| Proceeds from maturities of investments | 582.30M |
| Proceeds from sale of assets | 46.00M |
| Payments to acquire productive assets | -103.30M |
| Acquisition of business, net of cash, and intellectual property and other investing activities | -528.20M |
| Payments to acquire marketable securities | -911.30M |
| Item | Value |
|---|---|
| Proceeds from issuance of common stock relating to employee stock plans | 121.80M |
| Payment, tax withholding, share-based payment arrangement | -352.30M |
| Payments for repurchase of common stock | -1.12B |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 3.41B |
| Cash and cash equivalents, end of period | 2.05B |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support